Prurigo nodularis (PN) of Hyde is a highly pruritic condition that results from the vicious cycle of itching and scratching. An increasing number of case studies report PN-mimicking lesions in patients with confirmed autoimmune bullous dermatoses (AIBDs). The PN lesions usually precede the blister formation and thus raise the question about the pathogenic relation between the two conditions and the possible role of PN as a trigger of AIBDs. We shed light on PN in the context of AIBDs, especially regarding the clinical characteristics and pathogenesis of the PN-like phenotype of bullous pemphigoid, linear IgA bullous dermatosis, and dermatitis herpetiformis, as well as in the hereditary bullous dermatoses setting, namely, epidermolysis bullosa pruriginosa.
{"title":"Prurigo nodularis phenotype in the bullous dermatoses spectrum","authors":"Valeria Mateeva MD, PhD, Aylin Kafelova MD, Kossara Drenovska MD, PhD, Snejina Vassileva MD, PhD","doi":"10.1016/j.clindermatol.2025.03.012","DOIUrl":"10.1016/j.clindermatol.2025.03.012","url":null,"abstract":"<div><div><span>Prurigo nodularis (PN) of Hyde is a highly pruritic condition that results from the vicious cycle of itching and scratching. An increasing number of case studies report PN-mimicking lesions in patients with confirmed autoimmune </span>bullous dermatoses<span><span> (AIBDs). The PN lesions usually precede the blister formation and thus raise the question about the pathogenic relation between the two conditions and the possible role of PN as a trigger of AIBDs. We shed light on PN in the context of AIBDs, especially regarding the clinical characteristics and pathogenesis of the PN-like phenotype of bullous pemphigoid<span>, linear IgA bullous dermatosis, and dermatitis herpetiformis, as well as in the hereditary bullous dermatoses setting, namely, </span></span>epidermolysis bullosa pruriginosa.</span></div></div>","PeriodicalId":10358,"journal":{"name":"Clinics in dermatology","volume":"43 5","pages":"Pages 656-660"},"PeriodicalIF":2.2,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143673221","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-09-01DOI: 10.1016/j.clindermatol.2025.03.001
Uwe Wollina MD , Leonhard J. Hoenig MD , Lawrence Charles Parish MD, MD (Hon), FRCP (Edin)
The human skin has been a subject of medicine and art. The interest in the interaction of skin and the inner body had increased after the establishment of anatomy as a science long before dermatology was acknowledged as a medical discipline. In painting the body surface, the Inkarnat (flesh tone) represents a mixture of the superficial epidermis and dermis, plus the deeper musculature and vasculature, each contributing to the skin color. In the fine arts of the Renaissance, skin is understood as primarily a layer of material. The human skin can express feelings, emotions, and various states of mind. We analyze two works of the Italian artist Alberto Burri (1915-1995), who painted in the postwar period. He opens a window into human existence with his materials while showing tragedies and wounds.
{"title":"Xerosis cutis and wounded skin in modern art: Two works by Alberto Burri","authors":"Uwe Wollina MD , Leonhard J. Hoenig MD , Lawrence Charles Parish MD, MD (Hon), FRCP (Edin)","doi":"10.1016/j.clindermatol.2025.03.001","DOIUrl":"10.1016/j.clindermatol.2025.03.001","url":null,"abstract":"<div><div><span><span> The human skin has been a subject of medicine and art. The interest in the interaction of skin and the inner body had increased after the establishment of anatomy as a science long before </span>dermatology was acknowledged as a medical discipline. In painting the body surface, the </span><em>Inkarnat</em><span><span> (flesh tone) represents a mixture of the superficial epidermis and dermis, plus the deeper musculature and </span>vasculature, each contributing to the skin color. In the fine arts of the Renaissance, </span><em>skin</em> is understood as primarily a layer of material. The human skin can express feelings, emotions, and various states of mind. We analyze two works of the Italian artist Alberto Burri (1915-1995), who painted in the postwar period. He opens a window into human existence with his materials while showing tragedies and wounds.</div></div>","PeriodicalId":10358,"journal":{"name":"Clinics in dermatology","volume":"43 5","pages":"Pages 738-741"},"PeriodicalIF":2.2,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143639469","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-09-01DOI: 10.1016/j.clindermatol.2025.03.008
Sarah G. Brooks BA, Gil Yosipovitch MD
Prurigo nodularis is a chronic inflammatory skin disorder characterized by relentlessly pruritic, hyperkeratotic nodules. Recent studies have provided compelling evidence for the pivotal role of dysregulated interactions between the nervous and immune systems in its pathogenesis. This article reviews the latest findings on the neurogenic mechanisms contributing to prurigo nodularis, particularly how these processes lead to the sensation of increased itch intensity. Peripheral sensitization is primarily driven by abnormal innervation of histamine-independent, small unmyelinated C fibers, epidermal hypoplasia, and dermal hyperinnervation. This sensitization is further amplified by the cyclic release of neuropeptides such as Substance P, calcitonin gene-related peptide, and nerve growth factor. Although the mechanisms underlying central sensitization in prurigo nodularis remain less understood, it likely involves enhanced itch signaling in the dorsal spinal cord or a lowered threshold for itch perception. Additionally, parallels between pruritus and pain–such as allodynia and alloknesis, as well as hyperalgesia and hyperknesis-along with the association of prurigo nodularis with various comorbid systemic conditions, offer valuable insights into the disorder's pathology. A deeper understanding of the complex neural sensitization mechanisms in prurigo nodularis may lead to the identification of novel therapeutic targets, ultimately alleviating the burden of this debilitating condition.
{"title":"Evolving evidence in the neural sensitization of prurigo nodularis","authors":"Sarah G. Brooks BA, Gil Yosipovitch MD","doi":"10.1016/j.clindermatol.2025.03.008","DOIUrl":"10.1016/j.clindermatol.2025.03.008","url":null,"abstract":"<div><div><span><span><span>Prurigo nodularis is a chronic inflammatory </span>skin disorder<span> characterized by relentlessly pruritic, hyperkeratotic nodules. Recent studies have provided compelling evidence for the pivotal role of dysregulated interactions between the nervous and immune systems in its pathogenesis. This article reviews the latest findings on the neurogenic mechanisms contributing to prurigo nodularis, particularly how these processes lead to the sensation of increased itch intensity. Peripheral sensitization is primarily driven by abnormal innervation of histamine-independent, small unmyelinated C fibers, epidermal </span></span>hypoplasia<span>, and dermal hyperinnervation. This sensitization is further amplified by the cyclic release of neuropeptides such as Substance P, calcitonin gene-related peptide, and </span></span>nerve growth factor<span><span>. Although the mechanisms underlying central sensitization in prurigo nodularis remain less understood, it likely involves enhanced itch signaling in the dorsal spinal cord or a lowered threshold for itch perception. Additionally, parallels between pruritus and pain–such as allodynia and alloknesis, as well as </span>hyperalgesia and hyperknesis-along with the association of prurigo nodularis with various comorbid systemic conditions, offer valuable insights into the disorder's pathology. A deeper understanding of the complex neural sensitization mechanisms in prurigo nodularis may lead to the identification of novel therapeutic targets, ultimately alleviating the burden of this debilitating condition.</span></div></div>","PeriodicalId":10358,"journal":{"name":"Clinics in dermatology","volume":"43 5","pages":"Pages 626-632"},"PeriodicalIF":2.2,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143647446","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-09-01DOI: 10.1016/j.clindermatol.2025.07.006
Ioannis-Alexios Koumprentziotis MD , Eleni Kroumpouzos BA , Shohreh Delavar MD , George Kroumpouzos MD, PhD
Microneedling radiofrequency (MNRF) and exosome therapies have recently garnered attention as potential treatments for pattern hair loss (PHL). This study aimed to conduct a scoping review of these treatments and present a series of patients with PHL treated with MNRF followed by topical exosome application therapy. We searched the PubMed, Google Scholar, and Cochrane databases for relevant articles regarding MNRF and exosome treatments for PHL. Our search yielded two studies on MNRF and nine studies on exosome therapy, all of which demonstrated positive effects on hair regrowth. One of these studies specifically focused on MN combined with exosome therapy. In our current study, we prospectively evaluated the efficacy and safety of MNRF followed by topical exosome application in 20 patients (median age, 46 years), comprising 16 men and four women, with PHL. Clinical evaluations were conducted using macroscopic photographs and digital image analysis with a trichoscopy device at baseline and then again at three, six, and nine months after treatment. The median followup duration was 10 months. Our results revealed significant increases in mean hair density and diameter, along with high patient satisfaction. No adverse events were reported. The treatment response was found to be independent of sex and the severity of PHL. Overall, this study underscores the potential therapeutic benefits of the MNRF followed by topical exosome application therapy. Randomized controlled trials, however, are needed to confirm the efficacy of this therapy and to determine the optimal treatment parameters.
{"title":"Microneedling radiofrequency followed by topical exosome application therapy for pattern hair loss: A scoping review and prospective study","authors":"Ioannis-Alexios Koumprentziotis MD , Eleni Kroumpouzos BA , Shohreh Delavar MD , George Kroumpouzos MD, PhD","doi":"10.1016/j.clindermatol.2025.07.006","DOIUrl":"10.1016/j.clindermatol.2025.07.006","url":null,"abstract":"<div><div>Microneedling radiofrequency (MNRF) and exosome therapies have recently garnered attention as potential treatments for pattern hair loss (PHL). This study aimed to conduct a scoping review of these treatments and present a series of patients with PHL treated with MNRF followed by topical exosome application therapy. We searched the PubMed, Google Scholar, and Cochrane databases for relevant articles regarding MNRF and exosome treatments for PHL. Our search yielded two studies on MNRF and nine studies on exosome therapy, all of which demonstrated positive effects on hair regrowth. One of these studies specifically focused on MN combined with exosome therapy. In our current study, we prospectively evaluated the efficacy and safety of MNRF followed by topical exosome application in 20 patients (median age, 46 years), comprising 16 men and four women, with PHL. Clinical evaluations were conducted using macroscopic photographs and digital image analysis with a trichoscopy device at baseline and then again at three, six, and nine months after treatment. The median followup duration was 10 months. Our results revealed significant increases in mean hair density and diameter, along with high patient satisfaction. No adverse events were reported. The treatment response was found to be independent of sex and the severity of PHL. Overall, this study underscores the potential therapeutic benefits of the MNRF followed by topical exosome application therapy. Randomized controlled trials, however, are needed to confirm the efficacy of this therapy and to determine the optimal treatment parameters.</div></div>","PeriodicalId":10358,"journal":{"name":"Clinics in dermatology","volume":"43 5","pages":"Pages 742-751"},"PeriodicalIF":2.2,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144759330","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-09-01DOI: 10.1016/j.clindermatol.2025.07.002
Laurent Misery MD, PhD , Howard I. Maibach MD , John Koo MD , Mohammad Jafferany MD
Neurocosmetics have been used since the 1990s and are defined as products that are supposed to modulate the neuro-immuno-cutaneous system functioning at the epidermal level. They have many potential applications, such as sensitive skin, skin stress, skin aging, pigmentation disorders, redness, skin regeneration, and skin inflammation. Cosmetics with pleasant properties are not neurocosmetics, and nothing new is being offered. Of more concern, some pseudo-neurocosmetics contain agonists and antagonists of neurotransmitters and, subsequently, potential effects on the central nervous system. These products are not cosmetics. There is an urgent need to inform patients, especially those with psychologic fragility.
{"title":"Neurocosmetics are cosmetics, which mean that they could have effects only on skin","authors":"Laurent Misery MD, PhD , Howard I. Maibach MD , John Koo MD , Mohammad Jafferany MD","doi":"10.1016/j.clindermatol.2025.07.002","DOIUrl":"10.1016/j.clindermatol.2025.07.002","url":null,"abstract":"<div><div>Neurocosmetics have been used since the 1990s and are defined as products that are supposed to modulate the neuro-immuno-cutaneous system functioning at the epidermal level. They have many potential applications, such as sensitive skin, skin stress, skin aging, pigmentation disorders, redness, skin regeneration, and skin inflammation. Cosmetics with pleasant properties are not neurocosmetics, and nothing new is being offered. Of more concern, some pseudo-neurocosmetics contain agonists and antagonists of neurotransmitters and, subsequently, potential effects on the central nervous system. These products are not cosmetics. There is an urgent need to inform patients, especially those with psychologic fragility.</div></div>","PeriodicalId":10358,"journal":{"name":"Clinics in dermatology","volume":"43 5","pages":"Pages 702-703"},"PeriodicalIF":2.2,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144658506","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-09-01DOI: 10.1016/j.clindermatol.2025.09.001
Jaya Manjunath BS , Brenda Umenita Akinniyi MS , Alexander L. Kollhoff MD , Shawn G. Kwatra MD
Prurigo nodularis (PN) is a chronic inflammatory skin condition characterized by intense pruritus and hyperkeratotic nodules commonly found on the trunk and extremities. The pathogenesis of PN involves neuroimmune dysregulation, mediated by various inflammatory cytokines and neuropeptides. PN significantly impacts patients' quality of life. There is greater disease severity, increased itch intensity, and a more pronounced reduction in quality of life in PN compared with other individuals with chronic pruritus. PN is associated with a range of systemic comorbidities, including chronic kidney disease, cardiovascular disease, metabolic disorders, HIV and tuberculosis infection, hepatic disorders, and autoimmune diseases. Additionally, PN is frequently accompanied by psychiatric comorbidities such as depression, anxiety, and obsessive-compulsive disorder, further complicating management. Sleep disturbances and neurologic comorbidities, including neuropathic pain and central sensitization, are also common in PN patients. Diagnosis should include a comprehensive review of systems to assess for comorbidities and evaluate disease severity, guiding personalized treatment approaches. Management strategies aim to reduce itch severity and improve quality of life, often involving immunosuppressants, neuromodulators, or emerging biologics such as dupilumab.
{"title":"Comorbidities in prurigo nodularis","authors":"Jaya Manjunath BS , Brenda Umenita Akinniyi MS , Alexander L. Kollhoff MD , Shawn G. Kwatra MD","doi":"10.1016/j.clindermatol.2025.09.001","DOIUrl":"10.1016/j.clindermatol.2025.09.001","url":null,"abstract":"<div><div>Prurigo nodularis (PN) is a chronic inflammatory skin condition characterized by intense pruritus and hyperkeratotic nodules commonly found on the trunk and extremities. The pathogenesis of PN involves neuroimmune dysregulation, mediated by various inflammatory cytokines and neuropeptides. PN significantly impacts patients' quality of life. There is greater disease severity, increased itch intensity, and a more pronounced reduction in quality of life in PN compared with other individuals with chronic pruritus. PN is associated with a range of systemic comorbidities, including chronic kidney disease, cardiovascular disease, metabolic disorders, HIV and tuberculosis infection, hepatic disorders, and autoimmune diseases. Additionally, PN is frequently accompanied by psychiatric comorbidities such as depression, anxiety, and obsessive-compulsive disorder, further complicating management. Sleep disturbances and neurologic comorbidities, including neuropathic pain and central sensitization, are also common in PN patients. Diagnosis should include a comprehensive review of systems to assess for comorbidities and evaluate disease severity, guiding personalized treatment approaches. Management strategies aim to reduce itch severity and improve quality of life, often involving immunosuppressants, neuromodulators, or emerging biologics such as dupilumab.</div></div>","PeriodicalId":10358,"journal":{"name":"Clinics in dermatology","volume":"43 5","pages":"Pages 681-685"},"PeriodicalIF":2.2,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145063501","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-09-01DOI: 10.1016/j.clindermatol.2025.03.004
Akash Rau BS , Danyelle Dawes MD
Prurigo nodularis is a chronic, intensely pruritic eruption that results in excoriated papules, mostly on the extensor surfaces of the arms and legs. Previous studies have indicated that the condition disproportionally affects those of African descent. Although the etiology has not been fully elucidated, patients with prurigo nodularis have been found to have associated comorbidities such as hypertension, renal disease, and HIV infection. This review covers the principles of work-up and diagnosis of prurigo nodularis in skin of color patients as well as management considerations in this population.
{"title":"Diagnosis and management of prurigo nodularis in skin of color patients","authors":"Akash Rau BS , Danyelle Dawes MD","doi":"10.1016/j.clindermatol.2025.03.004","DOIUrl":"10.1016/j.clindermatol.2025.03.004","url":null,"abstract":"<div><div><span>Prurigo nodularis is a chronic, intensely pruritic eruption that results in excoriated papules, mostly on the extensor surfaces of the arms and legs. Previous studies have indicated that the condition disproportionally affects those of African descent. Although the etiology has not been fully elucidated, patients with prurigo nodularis have been found to have associated comorbidities such as hypertension, </span>renal disease<span>, and HIV infection. This review covers the principles of work-up and diagnosis of prurigo nodularis in skin of color patients as well as management considerations in this population.</span></div></div>","PeriodicalId":10358,"journal":{"name":"Clinics in dermatology","volume":"43 5","pages":"Pages 640-643"},"PeriodicalIF":2.2,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143639436","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-09-01DOI: 10.1016/j.clindermatol.2025.06.001
Leonard J. Hoenig MD , Uwe Wollina MD , Nick J. Levell MD, FRCP, MBA , Lawrence Charles Parish MD, MD (Hon), FRCP (Edin)
This contribution highlights the biographies of 12 physicians, 11 of whom were dermatologists, knighted by British monarchs over the past 150 years. They are: William JamesErasmus Wilson (1809-1884), Dyce Duckworth (1840-1928), Thomas McCall Anderson (1836-1908), Jonathan Hutchinson (1828-1913), Malcolm Morris (1849-1924), James Galloway (1862-1922), Aldo Castellani (1874-1971), Humphrey Rolleston (1862-1944), Norman Purvis Walker (1862-1942), Robert Bolam (1871-1939), Ernest Graham-Little (1867-1950), and Archibald M. H. Gray (1880-1967).
We also highlight the lives of two physicians honored as members of the Order of the British Empire: Nigel Vincent Delahunty Bunker (1927-1967) and dermatologist Nick J. Levell, as well as Nigel’s son, the noted dermatologist Christopher B. Bunker, who was awarded the 2019 Sir Archibald Gray Prize and Medal for outstanding work in dermatology.
{"title":"Dermatologists Who Have Been Knighted by the Kings and Queens of England","authors":"Leonard J. Hoenig MD , Uwe Wollina MD , Nick J. Levell MD, FRCP, MBA , Lawrence Charles Parish MD, MD (Hon), FRCP (Edin)","doi":"10.1016/j.clindermatol.2025.06.001","DOIUrl":"10.1016/j.clindermatol.2025.06.001","url":null,"abstract":"<div><div>This contribution highlights the biographies of 12 physicians, 11 of whom were dermatologists, knighted by British monarchs over the past 150 years. They are: William JamesErasmus Wilson (1809-1884), Dyce Duckworth (1840-1928), Thomas McCall Anderson (1836-1908), Jonathan Hutchinson (1828-1913), Malcolm Morris (1849-1924), James Galloway (1862-1922), Aldo Castellani (1874-1971), Humphrey Rolleston (1862-1944), Norman Purvis Walker (1862-1942), Robert Bolam (1871-1939), Ernest Graham-Little (1867-1950), and Archibald M. H. Gray (1880-1967).</div><div>We also highlight the lives of two physicians honored as members of the Order of the British Empire: Nigel Vincent Delahunty Bunker (1927-1967) and dermatologist Nick J. Levell, as well as Nigel’s son, the noted dermatologist Christopher B. Bunker, who was awarded the 2019 Sir Archibald Gray Prize and Medal for outstanding work in dermatology.</div></div>","PeriodicalId":10358,"journal":{"name":"Clinics in dermatology","volume":"43 5","pages":"Pages 712-722"},"PeriodicalIF":2.2,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144505035","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-09-01DOI: 10.1016/j.clindermatol.2025.02.006
Shannon Hanggodo BS , Timothy Klufas BA , Simran Saini BS , Albert E. Zhou MDPhD , Gillian Weston MD , Jane M. Grant-Kels MD
Professional ethics prohibit physicians from dating current patients due to risks of exploitation, compromised objectivity, and power imbalances, conflicting with obligations of beneficence and nonmaleficence. Online dating applications or appls" complicate these boundaries, as a physician's online presence may inadvertently enable patient encounters outside professional contexts. To maintain ethical standards, physicians should avoid sharing identifiable information on dating platforms, ensure patient care is transferred before pursuing romantic relationships, and adhere to institutional policies that mitigate risks and uphold transparency.
{"title":"From patients to partners: Ethical complexities of maintaining professional boundaries in a digital age","authors":"Shannon Hanggodo BS , Timothy Klufas BA , Simran Saini BS , Albert E. Zhou MDPhD , Gillian Weston MD , Jane M. Grant-Kels MD","doi":"10.1016/j.clindermatol.2025.02.006","DOIUrl":"10.1016/j.clindermatol.2025.02.006","url":null,"abstract":"<div><div>Professional ethics prohibit<span> physicians from dating current patients due to risks of exploitation, compromised objectivity, and power imbalances, conflicting with obligations of beneficence<span> and nonmaleficence. Online dating applications or appls\" complicate these boundaries, as a physician's online presence may inadvertently enable patient encounters outside professional contexts. To maintain ethical standards, physicians should avoid sharing identifiable information on dating platforms, ensure patient care is transferred before pursuing romantic relationships, and adhere to institutional policies that mitigate risks and uphold transparency.</span></span></div></div>","PeriodicalId":10358,"journal":{"name":"Clinics in dermatology","volume":"43 5","pages":"Pages 723-725"},"PeriodicalIF":2.2,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143413523","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
扫码关注我们
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号